Singapore

The study indicated that the reagent used in Lucence’s SAFER Sample saliva collection kit inactivates SARS-CoV-2 within 45 seconds of sample collection. 

The first batch of these devices will be delivered in the later half of this month, said Vivian Balakrishnan, Minister-in-charge of the Smart Nation initiative.

This follows the Singapore-based startup’s undisclosed amount of Series B funding in January 2020.

Researchers from SMART’s AMR IRG, NTU and MIT are working together to develop a rapid serological test and a rapid diagnostic test (RDT), based on protein detection.  

Professor Wang Linfa, Director of the Duke-NUS’ Emerging Infectious Diseases programme, and team conceived this research and invented the cPass diagnostic test.

Singapore-based HeartVoice, which was formed in February 2019 as a joint venture between both iAPPS and Omron Healthcare, announced last week that it will extend the use of its telehealth platform to all healthcare providers for free in the country until 31 July, 2020.

In addition to the funding, CXA Group has signed a MoU with Humanica to integrate its Human Capital Management platform with their platform in Thailand.

Mental health and well-being for healthcare workers have become an increasing concern, given their increased workloads and stress levels in coping with the COVID-19 pandemic.  

The Singapore-based startup was founded in 2019 and consists of a team of startup founders and psychologists. 

To date, the Fortitude Kit has been deployed in 13 Singapore hospitals and labs, public and private, and more than 20 countries internationally.